The median frequencies of MTB-specific CD4+ T-cells expressing CD27 did not alter over the duration of TB treatment for subjects with severe (p = 0.92) and mild lung impairment (p = 0.054) (Figure 3D). This evidence concerns the gene CD4 and tuberculosis.